Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$0.26 - $2959.0 $27,700 - $315 Million
106,539 Added 454.01%
130,005 $35,000
Q2 2022

Aug 09, 2022

BUY
$0.34 - $1.67 $2,438 - $11,977
7,172 Added 44.02%
23,466 $9,000
Q1 2022

May 17, 2022

BUY
$0.9 - $2.12 $14,664 - $34,543
16,294 New
16,294 $23,000

About TC BioPharm (Holdings) plc


  • Ticker TCBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,747,700
  • Market Cap $28.2M
  • Description
  • TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19...
More about TCBP
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.